Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Figures and Graphics
Haczynski J et al.  
Effect of moxonidine on left ventricular hypertrophy in hypertensive patients

Journal of Clinical and Basic Cardiology 2001; 4 (1): 61-65

PDF    Summary    Figures   


Figure
 
Moxonidin - enddiastolischer Durchmesser
Figure 1: Interventricular septum end-diastolic diameter (IVS EDD) at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 months (visit 7) moxonidine monotherapy.


Keywords: Diagrammend-diastolic diameterEnddiastolischer Durchmesserinterventricular septumInterventrikuläres SeptumMoxonidinmoxonidine
 
 
Moxonidin - enddiastolischer Durchmesser
Figure 2: Left ventricular posterior wall end-diastolic diameter (PW EDD) at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 month (visit 7) moxonidine monotherapy


Keywords: Diagrammend-diastolic diameterEnddiastolischer Durchmesserleft ventricular posterior walllinksventrikuläre HinterwandMoxonidinmoxonidine
 
 
Moxonidin - enddiastolischer Durchmesser
Figure 3: Left ventricular end-diastolic diameter (LV EDD) at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 month (visit 7) moxonidine monotherapy.


Keywords: Diagrammleft ventricular end-diastolid diameterlinksventrikulärer enddiastolischer DurchmesserMoxonidinmoxonidine
 
 
Moxonidin - linksventrikuläre Masse
Figure 4: Left ventricular (LV) mass at baseline (visit 1) and after 3 month (visit 5), 6 month (visit 6) and 9 month (visit 7) moxonidine monotherapy.


Keywords: Diagrammleft ventricular masslinksventrikuläre MasseMoxonidinmoxonidine
 
 
 
copyright © 2003–2017 Krause & Pachernegg GmbH | Sitemap | Impressum
 
Werbung